Invest Daily Pro
  • Economy
  • Investing
No Result
View All Result
  • Economy
  • Investing
No Result
View All Result
Invest Daily Pro
No Result
View All Result
Home Economy

Prestigious London Health Accelerator Accepts knus as Social Entrepreneurship School Participant

by
October 31, 2024
in Economy, Investing
0
Prestigious London Health Accelerator Accepts knus as Social Entrepreneurship School Participant
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

London, UK – knus, a leading health tech company, has been accepted into the prestigious School for Social Entrepreneurs (SSE) London Health Accelerator. This program, focused on supporting social enterprises addressing healthcare challenges and inequalities, will provide knus with valuable mentorship, industry expertise, and access to a powerful network to accelerate its mission of transforming mental health peer support through innovative digital solutions.

The SSE London Health Accelerator, in collaboration with MedCity and the UK Government’s UK Shared Prosperity Fund, is specifically designed for social enterprises working towards improving healthcare outcomes. The program’s unique curriculum is tailored to address the challenges of scaling social impact in the health sector, particularly in underserved communities.

Knus is a non-profit organization based in the UK that offers a free and confidential mental health peer support platform. The platform, designed to create a supportive community, connects service users with trained peer support coaches who have lived experiences with mental health challenges. Through this platform, individuals can discuss a variety of topics such as anxiety, depression, addiction, and bereavement in a safe online space. Volunteer coaches, guided by professionals such as doctors and social workers, offer resources and emotional support to users. Being accepted into the SSE London Health Accelerator is a significant achievement for knus as it aims to expand its reach and impact within the healthcare system.

Knus joins an impressive group of social entrepreneurs who share a commitment to addressing healthcare disparities and promoting community health. With the support of SSE London Health Accelerator, knus is looking forward to advancing its mission of making healthcare more accessible, informed, and equitable.

About knus (https://knus.io):

Knus is a pioneering health tech company dedicated to empowering service users and transforming mental healthcare delivery through digital innovation. By focusing on user-centric solutions, knus bridges the gap between technology and healthcare, enabling better-informed decisions and improving health outcomes.

About the School for Social Entrepreneurs (https://www.the-sse.org/):

The School for Social Entrepreneurs supports individuals from all backgrounds in tackling society’s biggest problems, with the vision of transforming lives and communities. Since 1997, the SSE has empowered over 2,500 social entrepreneurs and social impact organizations in the UK and beyond.

About MedCity (https://medcityhq.com):

MedCity is a life sciences cluster organization for London, fostering collaboration in the health, biotech, and medtech sectors to drive innovation, investment, and talent growth. Established by the Mayor of London, MedCity connects companies, researchers, and policymakers, supporting initiatives in drug discovery, medical devices, digital health, and data science. Its mission is to strengthen London’s position as a global science hub and improve health outcomes through partnerships and strategic support.

Distributed by Pressat (https://pressat.co.uk/):

This article has been distributed by Pressat, a leading press release distribution service based in the UK. Pressat helps organizations of all sizes gain media coverage and improve their online presence through effective and targeted distribution of press releases.

ShareTweetPin

Related Posts

RemSense Capital Raising
Investing

RemSense Capital Raising

August 4, 2025
Tech 5: Tesla and Samsung Strike Deal, Palo Alto to Acquire CyberArk
Investing

Tech 5: Tesla and Samsung Strike Deal, Palo Alto to Acquire CyberArk

August 3, 2025
Quimbaya Gold Announces Termination of LOI with Denarius Metals
Investing

Quimbaya Gold Announces Termination of LOI with Denarius Metals

August 2, 2025
Top 5 Canadian Mining Stocks This Week: Helius Metals Jumps 67 Percent
Investing

Top 5 Canadian Mining Stocks This Week: Helius Metals Jumps 67 Percent

August 2, 2025
Stallion Uranium Announces Update to Previously Announced Technology Licensing Agreement
Investing

Stallion Uranium Announces Update to Previously Announced Technology Licensing Agreement

August 1, 2025
Silver Crown Announces Amendment
Investing

Silver Crown Announces Amendment

August 1, 2025
Next Post
VPN for IoT: Securing Device Communications

VPN for IoT: Securing Device Communications

Recommended

Could Bitcoin Reach $200000? Market & Expert Insights

Could Bitcoin Reach $200000? Market & Expert Insights

March 2, 2025
NAS table tennis student-athletes strike gold at 2024 US Open

NAS table tennis student-athletes strike gold at 2024 US Open

December 29, 2024
RoK: A friend of long standing

RoK: A friend of long standing

September 17, 2024
How to Date on LovoFinder While Building a Successful Career

How to Date on LovoFinder While Building a Successful Career

November 26, 2024
Companies can make customers ambassadors of sustainability, hospitality expert says

Companies can make customers ambassadors of sustainability, hospitality expert says

November 17, 2024
More PHL executives now support cybersecurity, says Google Cloud expert

More PHL executives now support cybersecurity, says Google Cloud expert

September 18, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 InvestDailyPro. All Rights Reserved.

    Disclaimer: InvestDailyPro.com, its managers, its employees, and assigns (collectively InvestDailyPro ) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
    The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    No Result
    View All Result
    • About us
    • Contact us
    • Home
    • Privacy Policy
    • Suspicious engagement
    • Terms & Conditions
    • Thank you

    Copyright © 2025 investdailypro.com | All Rights Reserved